dcas9 ned (Addgene inc)
93
Structured Review
Addgene inc
dcas9 ned
Dcas9 Ned, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dcas9+ned/pdCas9-NED+(Plasmid+%23109358)/pmc12177974-43-2-3
Average 93 stars, based on 5 article reviews
Dcas9 Ned, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dcas9+ned/pdCas9-NED+(Plasmid+%23109358)/pmc12177974-43-2-3
Average 93 stars, based on 5 article reviews
dcas9 ned - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Functional Validation of the Putative Oncogenic Activity of PLAU Article Snippet: Plasmids pMLM3705 (dCas9-VP64) and MLM3636 (sgRNAs) were kind gifts from Keith Joung (Addgene plasmid #47754 and #43860, respectively), and CRISPRoff-v2.1 (OFF2.1) (DNMT3A/3L-dCas9-KRAB) from Jonathan S Weissman [ ] (Addgene Plasmid #167981). .. We used Article Title: Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approach Article Snippet: Plasmids pMLM3705 (dCas9-VP64) and MLM3636 (sgRNAs) were a kind gift from Keith Joung (Addgene plasmid #47754). .. We used Article Title: Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approach. Article Snippet: Plasmids pMLM3705 (dCas9-VP64) and MLM3636 (sgRNAs) were a kind gift from Keith Joung (Addgene plasmid #47754). .. We used Article Title: Functional Validation of the Putative Oncogenic Activity of PLAU . Article Snippet: Plasmids Encoding Transiently Expressed dCas9-Effector Domains Plasmids pMLM3705 (dCas9-VP64) and MLM3636 (sgRNAs) were kind gifts from Keith Joung (Addgene plasmid #47754 and #43860, respectively), and CRISPRoff-v2.1 (OFF2.1) (DNMT3A/3L-dCas9-KRAB) from Jonathan S Weissman [45] (Addgene Plasmid #167981). .. We used Negative Control:Article Title: Functional Validation of the Putative Oncogenic Activity of PLAU Article Snippet: Plasmids pMLM3705 (dCas9-VP64) and MLM3636 (sgRNAs) were kind gifts from Keith Joung (Addgene plasmid #47754 and #43860, respectively), and CRISPRoff-v2.1 (OFF2.1) (DNMT3A/3L-dCas9-KRAB) from Jonathan S Weissman [ ] (Addgene Plasmid #167981). .. We used Article Title: Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approach Article Snippet: Plasmids pMLM3705 (dCas9-VP64) and MLM3636 (sgRNAs) were a kind gift from Keith Joung (Addgene plasmid #47754). .. We used Article Title: Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approach. Article Snippet: Plasmids pMLM3705 (dCas9-VP64) and MLM3636 (sgRNAs) were a kind gift from Keith Joung (Addgene plasmid #47754). .. We used Article Title: Functional Validation of the Putative Oncogenic Activity of PLAU . Article Snippet: Plasmids Encoding Transiently Expressed dCas9-Effector Domains Plasmids pMLM3705 (dCas9-VP64) and MLM3636 (sgRNAs) were kind gifts from Keith Joung (Addgene plasmid #47754 and #43860, respectively), and CRISPRoff-v2.1 (OFF2.1) (DNMT3A/3L-dCas9-KRAB) from Jonathan S Weissman [45] (Addgene Plasmid #167981). .. We used |